You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KLH

Showing 1 - 25 of 161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uterine Fibroids (MeSH Heading: Leiomyoma) Trial (KLH-2109, Placebo)

Recruiting
  • Uterine Fibroids (MeSH Heading: Leiomyoma)
  • Multiple Locations, Japan
    Clinical Research Site
Nov 24, 2022

Immune Response Trial in Oxford (Keyhole-Limpet Hemocyanin, Saline, Montanide ISA 51 VG)

Recruiting
  • Immune Response
  • Keyhole-Limpet Hemocyanin
  • +3 more
  • Oxford, United Kingdom
    NIHR Oxford Experimental Medicine Clinical Research Facility
May 16, 2023

Uterine Fibroids (MeSH Heading: Leiomyoma) Trial (KLH-2109, Leuprorelin)

Not yet recruiting
  • Uterine Fibroids (MeSH Heading: Leiomyoma)
  • (no location specified)
Jul 19, 2022

Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

Active, not recruiting
  • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Incomplete Freund's Adjuvant
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 12, 2022

Hypophosphatasia Trial in Würzburg (Ilofotase Alfa, 0.8 mg/kg, Ilofotase Alfa, 3.2 mg/kg)

Recruiting
  • Hypophosphatasia
  • Ilofotase Alfa, 0.8 mg/kg
  • Ilofotase Alfa, 3.2 mg/kg
  • Würzburg, Germany
    Osteologie / Klinische Studieneinheit, Orthopädische Klinik - KL
May 26, 2023

Healthy Volunteers Trial in Hakata (ONO-4685, Placebo, KLH)

Completed
  • Healthy Volunteers
  • ONO-4685
  • +4 more
  • Hakata, Fukuoka, Japan
    Fukuoka Clinical Site
Nov 9, 2021

KLH and Imiquimod Induced Skin Inflammation in Healthy Volunteers Trial in Leiden (EDP1815, EDP2939, Placebo oral capsule)

Recruiting
  • KLH and Imiquimod Induced Skin Inflammation in Healthy Volunteers
  • Leiden, Netherlands
    Centre for Human Drug Research
Jan 11, 2023

Glioblastoma Trial (SurVaxM)

No longer available
  • Glioblastoma
  • (no location specified)
Nov 8, 2021

Multiple Myeloma Trial in Philadelphia, Houston (CD3/CD28)

Completed
Has Results
  • Multiple Myeloma
  • CD3/CD28
  • Philadelphia, Pennsylvania
  • +1 more
Dec 2, 2020

Neuroblastoma Trial in New York (adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH,

Active, not recruiting
  • Neuroblastoma
  • adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH
  • oral β-glucan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 11, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in Canada, United States (23-PPV, 13-PCV Booster, Influenza Vaccine)

Completed
Has Results
  • Multiple Sclerosis, Relapsing-Remitting
  • 23-PPV
  • +5 more
  • Cullman, Alabama
  • +21 more
Apr 4, 2022

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer Trial (immunological adjuvant OPT-821, polyvalent

Withdrawn
  • Fallopian Tube Cancer
  • +2 more
  • immunological adjuvant OPT-821
  • polyvalent antigen-KLH conjugate vaccine
  • (no location specified)
Feb 20, 2020

Relapsing Multiple Sclerosis Trial in Worldwide (Ofatumumab, Tetanus toxoid (TT) containing vaccine (Td, Tdap), 13-valent

Recruiting
  • Relapsing Multiple Sclerosis
  • Ofatumumab
  • +5 more
  • Birmingham, Alabama
  • +295 more
Jan 13, 2023

Healthy Volunteers Trial in Austin (SAR441344, , Keyhole limpet hemocyanin)

Completed
  • Healthy Volunteers
  • Austin, Texas
    PPD-Site Number:8400001
Apr 26, 2023

Metastatic Breast Cancer Trial in Worldwide (OPT-822/OPT-821(30 µg/100 µg), Phosphate Buffer Saline (PBS), Cyclophosphamide)

Completed
  • Metastatic Breast Cancer
  • OPT-822/OPT-821(30 μg/100 μg)
  • +2 more
  • Birmingham, Alabama
  • +42 more
Sep 14, 2020

Endometriosis Trial in Multiple Locations (KLH-2109, Placebo, Leuprorelin acetate)

Completed
  • Endometriosis
  • Multiple Locations, Japan
    (unnamed)
Jun 3, 2019

Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)

Recruiting
  • Metastatic Pancreatic Cancer
  • MesoPher
  • Mitazalimab
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Dec 6, 2022

Melanoma Trial in New York (DC Vaccine, Montanide Vaccine, Poly-ICLC)

Completed
  • Melanoma
  • DC Vaccine
  • +2 more
  • New York, New York
  • +1 more
Sep 13, 2022

Glioblastoma, Glioma Trial in New York (Bevacizumab, Peptide Vaccine, Poly-ICLC as immune adjuvant)

Withdrawn
  • Glioblastoma
  • Glioma
  • New York, New York
    NYU Perlmutter Cancer Center
Jan 8, 2020

Burden of Disease and Functional Impairment in XLH

Recruiting
  • X Linked Hypophosphatemia
  • no intervention
  • Wuerzburg, Germany
    Orthopedic Center for Musculoskeletal Research, Orthopedic Depar
Aug 30, 2022

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (autologous immunoglobulin

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • autologous immunoglobulin idiotype-KLH conjugate vaccine
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 2, 2019

Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Ovarian Carcinoma
  • XP-DC vaccinations
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Mar 6, 2023

Healthy Volunteer Trial in Leeds (Fimaporfin (Photosensitizer), Hiltonol (Poly-ICLC), HPV E7 (Human Papilloma Virus E7)

Completed
  • Healthy Volunteer
  • Fimaporfin (Photosensitizer)
  • +3 more
  • Leeds, United Kingdom
    Covance Clinical Research Unit Limited
Aug 22, 2019

HIV Trial in Boston, New York (ALVAC(2)120(B,MN)GNP (vCP1452), Keyhole-Limpet Hemocyanin)

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • Keyhole-Limpet Hemocyanin
  • Boston, Massachusetts
  • +1 more
Oct 28, 2021

Adults Treated With Asfotase Alfa for Hypophosphatasia

Completed
  • Hypophosphatasia
    • Würzburg, Germany
      Clinical Trial Unit, Orthopedic Department, Wuerzburg University
    Jul 11, 2022